USPTO serial 85219746
LINXON
Reviewed by CopyMark Law Group
Status 601
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- NEW APPLICATION PROCESSING
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with LINXON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christopher Serbagi
CHRISTOPHER SERBAGI LAW OFFICES OF CHRISTOPHER SERBAGI488 MADISON AVE STE 1120NEW YORK, NY 10022-5719UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of pain, hypertension, cardiovascular, respiratory, central nervous system and gastrointestinal diseases and disorders, Alzheimer's disease, dementia, AIDS-related dementia, neuropathic pain, diabetic neuropathy, neurological disorders, neurodegenerative disorders, depression and alcohol abuse, addiction and dependence; pharmaceutical preparations in the nature of a neuroprotective agent | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 25, 2011 | MAB1 | ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT | — |
| Jan 25, 2011 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Jan 24, 2011 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Jan 24, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 21, 2011 | NWAP | NEW APPLICATION ENTERED | — |